Publications

Search our bibliography using the filters on the right-hand side.

Displaying 301 through 347 of 347 publications.

Wertz DA, Pollack M, Bohn R, Rodgers K, Sacco P, Sullivan SD. Impact of asthma control on quality of life. Presented at the American Academy of Allergy, Asthma, and Immunology; May 2008. Washington, DC.

Briesacher B, Sacco P, Fouayzi H, Quittner A. Tobramycin inhaled solution utilization in cystic fibrosis patients in a privately insured US population. Poster presented at the American Thoracic Society; May 2008. Toronto, Canada.

Sullivan SD, Wertz D, Pollack M, Bohn R, Sacco P. Impact of asthma control on sleep, attendance at work, normal activities and burden. Poster presented at the Academy of Managed Care Pharmacy; April 2008. San Francisco, CA.

Weiner JR, Toy EL, Sacco P, Duh MS. Costs, quality of life, and treatment compliance associated with antibiotic therapies in patients with cystic fibrosis: a review of the literature expert. Expert Opin Pharmacother. 2008 Apr;9(5):751-66.

Price MA, Hill CD, Williams VSL, Morlock RJ, Leeuwenkamp O, Patterson TL. Measures of functional status and quality-of-life in schizophrenia. Curr Psychiatry Rev. 2008 Feb 1;4(1):28-38.

Williams RE, Bosnic N, Sweeney CT, Duncan AW, Levine KB, Brogan M, Cook SF. Prevalence of opioid dispensings and concurrent gastrointestinal medications in Quebec. Pain Res Manag. 2008;13(5):395-400.

Cook SF, Bell T, Sweeney CT, Fehnel SE, Hollis KA. Impact on quality of life of constipation associated gi symptoms related to opioid treatment in chronic pain patients: pAC-QoL results from the opioid survey. Poster presented at the 26th Annual Scientific Meeting of the American Pain Society; May 2007.

Cook SF, Bell TJ, Sweeney CT, Goss DS, Zhou X. Severity of constipation-associated gi symptoms related to opioid treatment in chronic pain patients: pac-sym questionnaire results from the opioid survey. Poster presented at the 26th Annual Scientific Meeting of the American Pain Society; May 2007.

Burch SP, Davis KH, Fehnel SE, Nelsen AC, Hill CD, Shashidhar KH. Outcomes, impact and behavior associated with acute treatment of migraine. Poster presented at the 16th Migraine Trust International Symposium; November 2006. [abstract] Cephalalgia. 2006 Nov; 26(11):1358-403.

Burch SP, Davis KH, Fehnel SE, Nelsen AC, Hill CD, Kori SH. The migraine assessment of current therapy (Migraine-ACT): a useful tool for detecting differences in outcomes between migraine therapies. Poster presented at the Migraine Trust International Symposium; September 2006.

Granger AL, Fehnel SE, Hogue SL, Bennett L, Edin HM. An assessment of patient preference and adherence to treatment with Wellbutrin SR: a web-based survey. J Affect Disord. 2006 Feb 1;90(2-3):217-21.

Reisetter BC, Dunson DH, Kolassa EM, Schwab P. CPMM Policy Report. Effect of Medicare part D reimbursement on community pharmacy profitability. 2006. Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi.

Tafesse E, Claxton A, Granger AL, Sanders J, Apelian D, Atillasoy E, Iloeje U. Estimates of health care costs for lamivudine-refractory chronic hepatitis b (CHB) patients. Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 18, 2005. [abstract] Value Health. 2005 May; 8(3):310.

Price MA. Standard-setting procedures report for the North Carolina checklist of academic standards (NCCLAS). 2005.

Price MA, Fiore T, Wilaby M. A study of the impact of schools attuned on special education services—phase two report. 2005.

Carroll I, Thomas JB, Dykstra LA, Granger AL, Allen RM, Howard JL, Pollard GT, Aceto MD, Harris LS. Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist. Eur J Pharmacol. 2004 Oct 6;501(1-3):111-9.

Burdett AN, Gard CC, Longo CJ, Raskin J, Gilsenan A, Hopkins JS, Miller DP. Prevalence and costs of difficult-to-treat depression in a Canadian claims database. Poster presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22, 2004. Bordeaux.

Walker EA, Picker MJ, Granger AL, Dykstra LA. Effects of opioids in morphine-treated pigeons trained to discriminate among morphine, the low-efficacy agonist nalbuphine, and saline. J Pharmacol Exp Ther. 2004 Jul;310(1):150-8.

Wilaby M, Price MA, Fiore T. A study of the impact of schools attuned on special education services— phase one report. 2004.

Fiore T, Tanner A, Price MA, Bernier K, Puma M, Magliocca L. Evaluation of the state improvement grant (SIG) program—third interim report. 2004.

Thase MF, Fava M, Hollander S, Simmons JH, Ivgy-May N, Boyle K, Gibertini M. Analysis of the effects of gepirone-ER on the Bech-6 and individual HAM-D 17-item scores. Poster presented at the 2003 42nd ACNP Annual Meeting; December 2003. San Juan, Puerto Rico.

Allen RM, Granger AL, Dykstra LA. The competitive N-methyl-D-aspartate receptor antagonist (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959) potentiates the antinociceptive effects of opioids that vary in efficacy at the mu-opioid receptor. J Pharmacol Exp Ther. 2003 Nov 1;307(2):785-92.

Granger AL, Fehnel SE, Bell T. Humanistic and financial impacts of restless legs syndrome form the patients' perspective. Poster presented at the 7th Congress of the European Federation of Neurological Societies; August 2003.

Sapienza S, Sacco P, Floyd K, DiCesare J, Doan Q. Results of a pilot pharmacotherapy quality improvement program using fixed-dose, combination amlodipine/benazepril antihypertensive therapy in a long-term care setting. Clin Ther. 2003 Jun;25(6):1872-87.

Price MA, Fiore T, Tanner A, Bernier K, Puma M, Magliocca L. Evaluation of the state improvement grant (SIG) program—updated cross project analysis report. 2003.

Sacco P, Luo R, Chang S, Sung D, Gause D. Potential benefits of rivastigmine in the nursing home population with alzheimer's disease. Poster presented at the Gerontological Society of America; December 2002. Boston, MA.

Dykstra LA, Granger AL, Allen RM, Zhang X, Rice KC. Antinociceptive effects of the selective delta opioid agonist SNC80 alone and in combination with mu opioids in the squirrel monkey titration procedure. Psychopharmacology (Berl). 2002 Oct 1;163(3-4):420-9.

Hollis KA, Duffer A. The use of panels as an effective means of collecting patient-reported outcomes. Presented at the Drug Information Association's 9th Annual Symposium for Quality of Life Evaluation; March 2002.

Allen RM, Granger AL, Dykstra LA. Dextromethorphan potentiates the antinociceptive effects of morphine and the delta-opioid agonist SNC80 in squirrel monkeys. J Pharmacol Exp Ther. 2002 Feb 1;300(2):435-41.

Fiore T, Tanner A, Price MA, Bernier K, Puma M, Magliocca L. Evaluation of the state improvement grant (SIG) program—second interim report. 2002.

Findling R, Reed M, Blumer J, Boyle K, van den Heuvel M. Mirtazapine pharmacokinetics in depressed children and adolescents. Poster presented at the 2001 American Academy of Child and Adolescent Psychiatry Conference; October 2001.

Jackson LM. Home study scores and mode of recruitment as indicators of field interviewer longevity and performance on the national household survey on drug abuse. Poster presented at the 20th Annual Southern Association for Public Opinion Research Conference; October 2001.

Allen RM, Granger AL, Dykstra LA. LY235959 potentiates the antinociceptive effects of morphine, l-methadone, levorphanol, butorphanol, and buprenorphine in a primate titration procedure. Poster presented at the College on the Problems of Drug Dependence; 2001.

Fiore T, Bryant K, Tanner A, Price MA, Bernier K, Puma M. Evaluation of the state improvement grant (SIG) program—first interim report. 2001.

Sacco P, Applegate P, Johnson J. A one-on-one health education program to improve medication compliance in the community-based elderly. Poster presented at the American Society of Consultant Pharmacists; January 2001. Chicago, IL.

Estrada CA, Unterborn JN, Price J, Thompson D, Gibson L. Judging the effectiveness of clinical pathways for pneumonia: the role of risk adjustment. Eff Clin Pract. 2000 Sep 1;3(5):221-8.

Dysktra LA, Granger AL. Interactions between the delta agonist SNC80, and the mu agonists, morphine, buprenorphine, and butorphanol in squirrel monkeys. Nida Res Monogr. 2000;180:65.

Allen RM, Granger AL, Dysktra LA. Dextromethorphan potentiates the antinociceptive effects of morphine and the delta-opioid agonist snc80 in a primate shock titration procedure. Poster presented at the College on the Problems of Drug Dependence; 2000.

Price MA. Standard-setting report for the compliance official qualification examination (series 14). 2000.

Cichy E, Price MA, Warren E. Job analysis report for the general securities sales supervisor qualification examination (series 8). 2000.

Sapienza S, Sacco P, Floyd K, DiCesare J, Doan Q. Hypertension management in long-term care: opportunities for quality improvement. Poster presented at the American Medical Directors Association; 2000. San Francisco, CA.

Sacco P, Katz J, Ulanday N. Treatment of skilled nursing facility residents with Resurfix. Poster presented at the American Society of Consultant Pharmacists; January 2000. Chicago, IL.

Rosen JB, Granger AL, Walker EA. Nalbuphine drug discriminations: effects of opioid peptide ctap. Poster presented at the 1st International Meeting of the Behavioral Pharmacology Society and European Behavioral Pharmacology Society; 1999.

Price MA, Fitzgerald K, Colonna A. Examination development report for the NYSE trading assistant qualification examination (series 25). 1999.

Jackson LM. Network position, power and knowledge of the political landscape: an analysis of emerging fisheries policy. Poster presented at the Southern Sociological Society annual meeting; April 1997.

Knox D, Gibson L, Zusman ME, Gallmeier C. Why college students end relationships. Coll Stud J. 1997 Jan 1;31(4):449-52.

The Multiple Sclerosis Study Group, Remavich M. Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: a randomized, double-blinded, placebo-controlled clinical trial. Ann Neurol. 1990 Jun;27(6):591-605. doi: 10.1002/ana.410270603